UGA Pharmaceutical and Biomedical Sciences
 
Search




Home
Message from the Department Head
Department Info
Faculty Research
Faculty Emeritus
Graduate Program
Student Life
Career Opportunities
Links
Links






 
Faculty and Research

 Faculty: View Alphabetically | Faculty: By Area of Research

Faculty: Biography

  Mandi Murph, Ph.D.
Assistant Professor
Pharmaceutical and Biomedical Sciences

Office: Room 376, R.C. Wilson Pharmacy Building
Phone: (706) 583-0216
E-mail: mmurph@rx.uga.edu

Biosketch
B.S. BiologyEmory UniversityAtlanta, GA1999
Ph.D., BiologyGeorgia Institute of TechnologyAtlanta, GA2005

Post-doctoral Experience
M.D. Anderson Cancer Center, Postdoctoral Fellow, Houston, TX, 2005-2008

Representative Publications
Yu, S.*, Murph M.M.*, Lu, Y.,Liu, S., Hall, H.S., Liu, J., Stephens,
L.C., Fang, X., Mills, G.B.. (*2008*) Lysophosphatidic acid receptors
determine tumorigenicity and aggressiveness of ovarian cancer cells. J
Natl Cancer Inst. Nov 19;100(22):1630-42.

Murph M.M, Nguyen, G.H., Radhakrishna, H. and Mills, GB. (*2008*)
Sharpening the edges of understanding the structure/function of the LPA1
receptor: expression in cancer and mechanisms of regulation. Biochim
Biophys Acta.. Sep;1781(9):547-557. PMID: 18501205

Hasegawa, Y.*, Murph, M.*, Yu, S., Tigyi, G. and.Mills, GB. (*2008*)
Lysophosphatidic acid (LPA)-induced vasodilator-stimulated
phosphoprotein mediates lamellipodia formation to initiate motility in
PC-3 prostate cancer cells. Mol. Oncol. 2(1):54-69. PMID: 19081821

Murph, M., Tanaka, T., Pang, J., Felix, E., Trost, R., Liu, S., Newman,
R., Mills, G.B. (*2007*) Liquid chromatography mass spectrometry for
quantifying plasma lysophospholipids; potential biomarkers for cancer
diagnosis. Methods Enzymol. 433:1-25. PMID:17954226.

Murph, M., Mills, G.B. (*2007*) Targeting the lipids LPA and S1P and
their signaling pathways for inhibition of tumor progression. Expert Rev
Mol Med. Oct 15;9(28):1-18. PMID: 17935635.

Murph M., Tanaka T., Liu S., Mills G.B. (*2006*). Of spiders and crabs:
the emergence of lysophospholipids and their metabolic pathways as
targets for therapy in cancer. Clin Cancer Res. 12(22):6598-602. PMID:
17121877.